Engineering 2, Room 599
Join S&J Visiting Scholars Declan Kuch and Matthew Kearnes in an informal discussion on how proponents of the bio-nano sciences, centered around polymer chemistry, have promised a new generation of targeting agents that will carry drug payloads to diseased cells with greater accuracy. Alongside these promises, proponents of precision medicine have sought to build new knowledge about health and illness through massive new databases that combine multiple ‘-omics’ with lifestyle and chemical exposure data. Much has already been written speculating about both the efficacy and social effects ‘downstream’ of these sciences, especially the likely consequences of precision medicine in domains of socio-economics, race and disability (Juengst et al., 2016; Meagher et al., 2016).We instead seek to discuss how these critiques are (or are not) affecting laboratory designs, practices, and methods, starting with a discussion of critiques of bio-nano science (Torrice, 2016; Wilhelm et al., 2016). How can bio-nano science and precision medicine practically address their critics in such disciplines as public health and sociology dismissing them as expensive indulgences to benefit mostly rich white people? What role can data sharing play in building public support? How can the open science ethos of bio-nano and much precision medicine research translate into public benefit considering the expanding ‘pharmaceuticalisation’ of illness (Dumit, 2012) and rising drug prices?
Declan Kuch is a Research Fellow in the School of Humanities and Languagues at UNSW. His research is situated between the fields of Science and Technology Studies and Economic Sociology. He has published on topics including public engagement with science and technology, precision medicine, energy and climate policy, and the sharing economy. He is the author of ‘The Rise and Fall of Carbon Emissions Trading’ (Palgrave MacMillan, 2015) and loves riding bikes.
Matthew Kearnes is an Australian Research Council Future Fellow, a CI with the ARC Centre of Excellence in Convergent Bio-Nano Science & Technology (CBNS) and member of the of Environmental Humanities Group at the School of Humanities and Languages, University of New South Wales. Matthew’s research is situated between the fields of Science and Technology Studies (STS), human geography and contemporary social theory. His current work is focused on the social and political dimensions of technological and environmental change, including ongoing work on nanotechnology, precision medicine, geoengineering and the development of negative emission strategies to anthropogenic climatic change. He has published widely on the ways in which the development of novel and emerging technologies is entangled with profound social, ethical and normative questions. Matthew serves on the editorial board Science, Technology and Society (Sage) and is an associate editor for Science as Culture (Taylor & Francis). Matthew is also co-convenor of the 4S 2018 conference, to be held in Sydney in August 2018.
- Dumit J. (2012) Drugs for life: how pharmaceutical companies define our health, Durham, NC: Duke University Press.
- Juengst E, McGowan ML, Fishman JR, et al. (2016) From “personalized” to “precision” medicine: the ethical and social implications of rhetorical reform in genomic medicine. Hastings Center Report 46: 21-33.
- Meagher KM, McGowan ML, Settersten RA, et al. (2016) Precisely Where Are We Going? Charting the New Terrain of Precision Prevention. Annual Review of Genomics and Human Genetics.
- Torrice M. (2016) Does Nanomedicine Have a Delivery Problem? ACS Central Science 2: 434-437.
- Wilhelm S, Tavares AJ, Dai Q, et al. (2016) Analysis of nanoparticle delivery to tumours. Nature Reviews Materials 1: 16014.